JP2020528082A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020528082A5 JP2020528082A5 JP2020524719A JP2020524719A JP2020528082A5 JP 2020528082 A5 JP2020528082 A5 JP 2020528082A5 JP 2020524719 A JP2020524719 A JP 2020524719A JP 2020524719 A JP2020524719 A JP 2020524719A JP 2020528082 A5 JP2020528082 A5 JP 2020528082A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cpp
- sequence listing
- therapeutic agent
- rpe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C*(C*(C)NC(N)=N)C(CC(C)=O)NC Chemical compound C*(C*(C)NC(N)=N)C(CC(C)=O)NC 0.000 description 5
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762533231P | 2017-07-17 | 2017-07-17 | |
| US62/533,231 | 2017-07-17 | ||
| PCT/US2018/042410 WO2019018350A1 (en) | 2017-07-17 | 2018-07-17 | TOPICAL ADMINISTRATION OF THERAPEUTIC AGENTS COMPRISING CELL PENETRATION PEPTIDES, FOR USE IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER OCULAR DISEASES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020528082A JP2020528082A (ja) | 2020-09-17 |
| JP2020528082A5 true JP2020528082A5 (https=) | 2021-10-21 |
Family
ID=63104068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020524719A Pending JP2020528082A (ja) | 2017-07-17 | 2018-07-17 | 加齢黄斑変性と他の眼疾患の治療用の細胞透過性ペプチドを使用する治療薬の局所送達 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10905770B2 (https=) |
| EP (1) | EP3654941A1 (https=) |
| JP (1) | JP2020528082A (https=) |
| CN (1) | CN112996486A (https=) |
| AU (1) | AU2018302022A1 (https=) |
| CA (1) | CA3070241A1 (https=) |
| IL (1) | IL272105A (https=) |
| WO (1) | WO2019018350A1 (https=) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200134287A (ko) * | 2018-04-02 | 2020-12-01 | 젠켐 테크놀로지 컴퍼니 리미티드 (베이징) | 타겟성을 구비하는 세포막 투과 펩타이드-다중팔 폴리에틸렌글리콜-약물 켤레체 및 그 응용 |
| JP7477457B2 (ja) | 2018-04-03 | 2024-05-01 | エヌジーエム バイオファーマシューティカルス，インコーポレーテッド | Ｃ３結合薬及びその使用方法 |
| TW202009013A (zh) * | 2018-08-14 | 2020-03-01 | 優你康光學股份有限公司 | 具有功能性成分的隱形眼鏡及其產品 |
| GB201900728D0 (en) * | 2019-01-18 | 2019-03-06 | Univ Birmingham | Drug delivery system |
| US12115212B2 (en) * | 2019-01-18 | 2024-10-15 | L & J Bio Co., Ltd. | Methods of decreasing amyloid beta (Aβ) plaque deposition and hyperphosphorylated tau plaque deposition in Alzheimer's disease using a cystatin C fusion protein |
| TW202100179A (zh) * | 2019-03-08 | 2021-01-01 | 美商Ｒａ製藥公司 | 補體活性之調節劑 |
| EP3953395B1 (en) * | 2019-04-08 | 2026-05-06 | Biocryst Pharmaceuticals, Inc. | Plasma kallikrein inhibitors and methods of use thereof in ocular disorders |
| WO2020252453A1 (en) * | 2019-06-14 | 2020-12-17 | The Brigham And Women's Hospital, Inc. | Membrane attack complexes and uses thereof |
| EP4050997A4 (en) * | 2019-10-30 | 2022-11-30 | Perfuse Therapeutics, Inc. | TREATMENT OF EYE DISEASES USING ENDOTHELIN RECEPTOR ANTAGONISTS |
| KR20220118419A (ko) * | 2019-12-19 | 2022-08-25 | 액티브 바이오테크 에이비 | 과도한 혈관신생과 관련된 안구 질병의 치료를 위한 화합물 |
| CA3168810A1 (en) | 2020-02-06 | 2021-08-12 | Perfuse Therapeutics, Inc. | Compositions for treatment of ocular diseases |
| JP2023515827A (ja) * | 2020-02-28 | 2023-04-14 | ノースウェスタン ユニバーシティ | 房水流出を高め、眼圧を減少させる方法 |
| WO2021202836A1 (en) * | 2020-04-01 | 2021-10-07 | The Trustees Of The University Of Pennsylvania | Factor b inhibitors and uses thereof |
| US11754753B2 (en) | 2020-04-27 | 2023-09-12 | Coopervision International Limited | Antioxidant contact lens |
| FR3111913A1 (fr) * | 2020-06-30 | 2021-12-31 | Eyevensys | Construction d’adn pour le traitement de pathologies oculaires |
| CN111671922B (zh) * | 2020-07-23 | 2023-03-21 | 四川大学华西医院 | 两亲性梳形嵌段接枝共聚物基超声造影剂及其制备方法 |
| CN114073774A (zh) * | 2020-08-17 | 2022-02-22 | 奥朗生物医药有限公司 | 药物和野生型穿膜肽衍生物的组合物 |
| CN116390723B (zh) | 2020-09-09 | 2024-12-31 | 社会利益网络公司 | 用于将生物素递送至线粒体的方法和组合物 |
| KR102556731B1 (ko) * | 2020-09-29 | 2023-07-21 | 주식회사 젠센 | 단백질 수송 도메인, 이를 포함하는 융합 화합물 및 이 융합 화합물을 포함하는 약학 조성물 |
| IL301769A (en) * | 2020-10-01 | 2023-05-01 | Abionyx Pharma Sa | Methods for treating eye diseases using lipid binding protein-based complexes |
| JP2023546757A (ja) | 2020-10-22 | 2023-11-07 | シークエル・バイオ・インコーポレイテッド | ペプチド製剤および眼科におけるその使用 |
| AU2021368859A1 (en) * | 2020-10-28 | 2023-06-22 | The Florey Institute Of Neuroscience And Mental Health | Peptide-based delivery of agents |
| CN114790225B (zh) * | 2021-01-26 | 2024-09-10 | 清华大学 | 一种新型内体逃逸肽及其应用 |
| EP4305055A4 (en) * | 2021-03-09 | 2025-07-02 | Univ Florida State Res Found | LIPID VESICLE-MEDIATED DELIVERY TO CELLS |
| CN113057142B (zh) * | 2021-03-30 | 2022-12-09 | 四川大学华西医院 | 一种视网膜内和/或视网膜下纤维化动物模型的构建方法 |
| US20240216520A1 (en) * | 2021-04-06 | 2024-07-04 | University Of South Florida | Peptide-small interfering rna-hyaluronic acid nanoparticles and methods of use thereof |
| CA3218398A1 (en) * | 2021-04-30 | 2022-11-03 | Perfuse Therapeutics, Inc. | Treatment of ocular diseases using endothelin receptor antagonists |
| EP4329753A4 (en) * | 2021-04-30 | 2025-02-26 | Perfuse Therapeutics, Inc. | PHARMACEUTICAL COMPOSITIONS AND INTRAVITREAL DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF EYE DISEASES |
| CN113332450B (zh) * | 2021-05-11 | 2023-08-04 | 铜仁学院 | 一种眼部给药递释系统氧化锌纳米粒的制备方法及其使用方法和应用 |
| WO2022251543A1 (en) * | 2021-05-28 | 2022-12-01 | Alexion Pharmaceuticals, Inc. | Use of complement factor d inhibitor for treatment of geographic atrophy secondary to age-related macular degeneration |
| CN113476587B (zh) * | 2021-07-19 | 2022-07-12 | 河南大学 | 一种脑靶向的神经保护剂ss31-ha-rt及其制备方法和应用 |
| CN113925966B (zh) * | 2021-09-17 | 2022-10-04 | 西安电子科技大学 | 快速响应型细胞核靶向纳米诊疗探针的制备方法 |
| CN114404429B (zh) * | 2021-11-30 | 2023-06-30 | 重庆医科大学附属第二医院 | 一种纳米银修饰的单宁酸-铁网络的载药纳米复合物及其制备方法和逆转肿瘤耐药应用 |
| KR102795182B1 (ko) * | 2022-02-18 | 2025-04-15 | (주)메디톡스 | 탈모 치료 또는 발모 촉진 활성을 갖는 폴리펩티드 및 그의 용도 |
| US20230310380A1 (en) * | 2022-04-05 | 2023-10-05 | Alan Neil Glazier | Methods, devices, and systems for treating lens protein aggregation diseases |
| AU2023250345A1 (en) | 2022-04-06 | 2024-11-14 | Abionyx Pharma Sa | Methods for treating eye diseases using lipid binding protein-based complexes |
| CN116444678B (zh) * | 2022-10-18 | 2024-02-02 | 百葵锐(深圳)生物科技有限公司 | 一种具有真菌抗菌抑菌性能的新型多肽 |
| WO2024102746A1 (en) * | 2022-11-08 | 2024-05-16 | Microcures, Inc. | Methods and agents for treating neurotrophic keratitis |
| WO2024156871A1 (en) * | 2023-01-27 | 2024-08-02 | Glasspearl Oü | Mixtures of lipid nanoparticles and cell penetrating peptides |
| WO2024160819A1 (en) | 2023-01-30 | 2024-08-08 | Consorcio Centro De Investigación Biomédica En Red | Nanoparticles with antibodies for ocular treatment |
| WO2024178368A2 (en) * | 2023-02-23 | 2024-08-29 | Ohio State Innovation Foundation | Therapeutic protein combinations |
| CN116270974B (zh) * | 2023-03-09 | 2024-03-12 | 湖南大学 | 一种组合物、阿柏西普递送系统和制备方法 |
| TWI877652B (zh) * | 2023-06-14 | 2025-03-21 | 長庚大學 | 眼用藥物遞送載體及其應用 |
| WO2025093129A1 (en) * | 2023-11-01 | 2025-05-08 | Newamsterdam Pharma B.V. | Treatment and prevention of age-related macular degeneration using a cetp inhibitor |
| WO2025093436A1 (en) * | 2023-11-01 | 2025-05-08 | Newamsterdam Pharma B.V. | Treatment and prevention of age-related macular degeneration using a cetp inhibitor |
| WO2025117721A1 (en) * | 2023-11-27 | 2025-06-05 | Massachusetts Institute Of Technology | Reconstituted lipoprotein particles to rescue lipid defects in the alzheimer's brain |
| WO2025128821A1 (en) * | 2023-12-12 | 2025-06-19 | Juvena Therapeutics, Inc. | Compositions and methods for adp-ribosylation factor molecular trafficking |
| WO2025147589A1 (en) * | 2024-01-05 | 2025-07-10 | Osanni Bio, Inc. | Implants, compositions, and methods for treating retinal diseases and disorders |
| WO2025212745A1 (en) * | 2024-04-04 | 2025-10-09 | University Of Massachusetts | Engineered adeno-associated virus (aav) capsid protein and uses thereof |
| CN118290598B (zh) * | 2024-05-29 | 2024-09-27 | 深圳柏垠生物科技有限公司 | 重组纤连蛋白及其制备方法和应用 |
| WO2026033482A1 (en) * | 2024-08-08 | 2026-02-12 | Universita' Degli Studi Di Torino | Therapeutic contact lenses loaded with mucin-based nanoparticles |
| CN118995345B (zh) * | 2024-08-09 | 2025-09-26 | 山西医科大学 | 一种抑制角膜缺氧损伤和角膜新生血管的隐形眼镜护理液及其制备方法 |
| WO2026034435A1 (ja) * | 2024-08-09 | 2026-02-12 | 東亞合成株式会社 | ペプチドフラグメント及びその利用 |
| WO2025218147A1 (zh) * | 2024-08-09 | 2025-10-23 | 山西医科大学 | 一种抑制角膜缺氧损伤和角膜新生血管的隐形眼镜护理液及其制备方法 |
| CN119746027A (zh) * | 2025-01-10 | 2025-04-04 | 山东济肽生物科技有限公司 | 多肽组合物的应用及治疗衰老相关皮肤病的组合物 |
| CN119792574B (zh) * | 2025-01-10 | 2025-12-19 | 宁夏医科大学 | 一种仿生plga复合纳米材料及其制备方法与应用 |
| CN121253831A (zh) * | 2025-10-31 | 2026-01-02 | 宁波大学附属人民医院 | 一种用于检测rvo-me抗vegf治疗分型的生物标志物及其应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19548114C2 (de) | 1995-12-21 | 2000-04-27 | Deutsches Krebsforsch | Konjugat, umfassend einen Wirkstoff, ein Polypeptid und einen Polyether |
| CN1263473A (zh) | 1997-05-21 | 2000-08-16 | 利兰·斯坦福青年大学托管委员会 | 增加跨生物膜转运的组合物和方法 |
| US7229961B2 (en) | 1999-08-24 | 2007-06-12 | Cellgate, Inc. | Compositions and methods for enhancing drug delivery across and into ocular tissues |
| CA2383499C (en) | 1999-10-21 | 2009-11-24 | Alcon Universal Ltd. | Drug delivery device |
| US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| US6589948B1 (en) | 2000-11-28 | 2003-07-08 | Eukarion, Inc. | Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| US7470659B2 (en) * | 2001-12-07 | 2008-12-30 | The Regents Of The University Of California | Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM) |
| SE0201863D0 (en) | 2002-06-18 | 2002-06-18 | Cepep Ab | Cell penetrating peptides |
| CA2530407A1 (en) | 2003-07-23 | 2005-02-03 | The Regents Of The University Of California | Penetration enhancer combinations for transdermal delivery |
| WO2009129625A1 (en) | 2008-04-22 | 2009-10-29 | Merck Frosst Canada Ltd. | Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| US20170157038A1 (en) | 2008-11-13 | 2017-06-08 | Gholam A. Peyman | Ophthalmic drug delivery method |
| US10272035B2 (en) | 2008-11-13 | 2019-04-30 | Gholam A. Peyman | Ophthalmic drug delivery method |
| JP2013523149A (ja) | 2010-04-09 | 2013-06-17 | メルク・シャープ・エンド・ドーム・コーポレイション | 新規な単一化学物質およびオリゴヌクレオチドの送達方法 |
| MX2012014573A (es) | 2010-06-24 | 2013-02-21 | Univ Indiana Res & Tech Corp | Agentes medicinales unidos a dipeptido. |
| ES2624626T3 (es) | 2011-11-03 | 2017-07-17 | Bayer Intellectual Property Gmbh | Ligadores basados en tirosina para la conexión desprendible de péptidos |
| WO2013086493A1 (en) | 2011-12-09 | 2013-06-13 | The Children's Hospital Of Philadelphia | Compositions and methods for the generation of activated protein c and methods of use thereof |
| MX373894B (es) * | 2012-11-08 | 2020-07-09 | Clearside Biomedical Inc | Métodos y dispositivos para el tratamiento de trastornos oculares en sujetos humanos. |
| EP2968391A1 (en) | 2013-03-13 | 2016-01-20 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
| GB201401453D0 (en) | 2014-01-28 | 2014-03-12 | Univ Birmingham | Transmucosal and transepithelial drug delivery system |
| GB201403268D0 (en) | 2014-02-25 | 2014-04-09 | Univ Birmingham | Antimicrobial surface |
| PT3155017T (pt) | 2014-05-28 | 2024-05-14 | Mederis Diabetes Llc | Farmacêuticos peptídicos melhorados para resistência à insulina |
| PH12018500745B1 (en) * | 2015-10-14 | 2023-03-15 | Massachusetts Eye & Ear Infirmary | High-dose statins for age-related macular degeneration |
| CN106668860B (zh) | 2015-11-09 | 2019-11-22 | 烟台大学 | 靶向眼后段的递药系统及其制剂和制备方法 |
| AU2018226872A1 (en) * | 2017-03-03 | 2019-09-05 | Macregen, Inc. | Treatment of age-related macular degeneration and other eye diseases with one or more therapeutic agents |
-
2018
- 2018-07-17 JP JP2020524719A patent/JP2020528082A/ja active Pending
- 2018-07-17 WO PCT/US2018/042410 patent/WO2019018350A1/en not_active Ceased
- 2018-07-17 US US16/037,432 patent/US10905770B2/en not_active Expired - Fee Related
- 2018-07-17 EP EP18749975.1A patent/EP3654941A1/en not_active Withdrawn
- 2018-07-17 CN CN201880059888.2A patent/CN112996486A/zh active Pending
- 2018-07-17 CA CA3070241A patent/CA3070241A1/en not_active Abandoned
- 2018-07-17 AU AU2018302022A patent/AU2018302022A1/en not_active Abandoned
-
2020
- 2020-01-16 IL IL272105A patent/IL272105A/en unknown
- 2020-12-04 US US17/112,339 patent/US20210085797A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10905770B2 (en) | Topical delivery of therapeutic agents using cell-penetrating peptides for the treatment of age-related macular degeneration and other eye diseases | |
| JP2020528082A5 (https=) | ||
| US20180296525A1 (en) | Treatment of age-related macular degeneration and other eye diseases with one or more therapeutic agents | |
| JP2020514407A (ja) | アポリポプロテイン模倣物を用いる加齢黄斑変性と他の眼疾患の治療 | |
| US20210138034A1 (en) | Treatment of age-related macular degeneration and other eye diseases with apolipoprotein mimetics | |
| US11413322B2 (en) | Immunotherapy for angiogenic disease | |
| US10766942B2 (en) | Fragments of syndecan-2 having anti-angiogenic activity | |
| ES2644016T3 (es) | Péptidos para su uso en el tratamiento tópico de enfermedades neurodegenerativas retinianas, en particular en estadios tempranos de retinopatía diabética y otras enfermedades retinianas en las que la neurodegeneración desempeña un papel esencial | |
| EP3224278A1 (en) | Methods and formulations for treating vascular eye diseases | |
| EP3238746B1 (en) | High-density lipoprotein, and delivery of drug to posterior segment of eye by ocular instillation of said cytophilic peptide-fused high-density lipoprotein | |
| CN109937053A (zh) | 用于治疗黄斑变性的含有mTOR抑制剂的药物组合物 | |
| US20160022769A1 (en) | Compostions and methods for treating retinal disease | |
| US20240299564A1 (en) | Peptide carriers and delivery to the eye of a subject | |
| JP6944463B2 (ja) | 眼疾患の治療のための組成物及び方法 | |
| US20240000891A1 (en) | Growth and differentiation factor 15 for treatment of proliferative vitreoretinopathy therapy | |
| JP2020518675A (ja) | ノリン誘発性の遺伝子発現および疾患を処置するためのその使用 | |
| KR20180102091A (ko) | 당뇨병의 치료를 위한 약제학적 제제 | |
| HK40011780A (en) | Treatment of age-related degeneration and other eye diseases with apolipoprotein mimetics | |
| HK1245149A1 (en) | Wt1 immunotherapy for intraocular angiogenic disease |